美股异动丨Hims & Hers Health一度涨超6.8% 公司计划明年进军加拿大市场

格隆汇
Jul 09, 2025

远距医疗公司Hims & Hers Health(HIMS.US)盘初一度涨超6.8%,最高触及52.33美元。消息面上,Hims & Hers Health计划明年进军加拿大市场。诺和诺德旗下Ozempic的主要成分索马鲁肽(semaglutide)的专利在加拿大比其他国家先到期,公司表示,届时Hims & Hers计划透过其数码平台提供低成本的治疗方案,并提供获得授权的医疗机构和个人化护理计划。(格隆汇)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10